FDA approves monthly subcutaneous amivantamab plus lazertinib for EGFR-mutated advanced NSCLC, cutting clinic time and ...
For the first time ever, an anti-aging drug is providing hope for millions who suffer from this common condition.
Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the ...
The spinal cord (SC) serves as the primary relay for sensory information originating in the periphery and transmitted to the brain for processing. Sensitive primary afferent fibers project to the ...
Senate Bill 11 was introduced as lethal injection drugs have become more expensive and hard to get, leading some states to turn to other methods.
Diabetes significantly impairs bone healing via several mechanisms, including sustained inflammation, oxidative stress, and poor osteogenic responses. Fully reduced isoform of High Mobility Group Box ...
Eye injection of fatty acid restores vision in elderly mice, showing promising results for human use
Injecting a fatty acid that is used to make very long fat molecules into the eyes of elderly mice improved their vision for up to a month, indicating that the natural compound could potentially be ...
The Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for Leqembi ® Iqlik ™, a once weekly lecanemab-irmb subcutaneous (SC) injection, for maintenance dosing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results